Skip to main content

TRUPANION INC

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

TRUP$34.26-3.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Parent Company Financials

Trupanion, Inc.Condensed Statements of Operations and Comprehensive Loss(Parent Company Only, in thousands)
Year Ended December 31,
202320222021
Expenses:
Veterinary invoice expense$253$4,144$4,538
Other cost of revenue2402,3402,610
Technology and development1,5074,9303,130
General and administrative5,34516,34611,714
New pet acquisition expense8069,3519,177
Depreciation and amortization494289473
Total expenses8,64537,40031,642
Loss from investment in joint venture(237)(192)(33)
Operating loss(8,882)(37,592)(31,675)
Interest expense11,9984,255(2)
Other income, net(14,442)(8,047)(5,755)
Loss before equity in undistributed earnings of subsidiaries(6,438)(33,800)(25,918)
Income tax benefit15,76614,54412,272
Equity (loss) in undistributed earnings of subsidiaries(54,021)(25,416)(21,884)
Net loss$(44,693)$(44,672)$(35,530)
Other comprehensive income (loss), net of taxes:
Other comprehensive income (loss) of subsidiaries6,704(9,378)6
Other comprehensive income (loss)6,704(9,378)6
Comprehensive loss$(37,989)$(54,050)$(35,524)
Trupanion, Inc.Condensed Balance Sheets(Parent Company Only)(In thousands, except share data)
December 31,
20232022
Assets
Current assets:
Cash and cash equivalents$10,994$16,052
Accounts and other receivables15,739
Prepaid expenses and other assets804697
Total current assets11,79922,488
Restricted cash22,96319,032
Property and equipment, net3,9812,398
Intangible assets, net5,8085,710
Other long-term assets12,54013,960
Advances to and investments in subsidiaries377,031312,559
Total assets$434,122$376,147
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable, accrued liabilities, and other current liabilities$336$484
Long-term debt - current portion1,350750
Total current liabilities1,6861,234
Long-term debt127,58068,354
Deferred tax liabilities1,1061,100
Other liabilities28162
Total liabilities130,40070,850
Stockholders’ equity:
Common stock: $0.00001 par value per share, 100,000,000 shares authorized; 42,887,052 and 41,858,866 shares issued and outstanding at December 31, 2023; 42,041,344 and 41,013,158 shares issued and outstanding at December 31, 2022——
Preferred stock: $0.00001 par value per share, 10,000,000 shares authorized; no shares issued and outstanding——
Additional paid-in capital536,108499,694
Accumulated other comprehensive income (loss)403(6,301)
Accumulated deficit(216,255)(171,562)
Treasury stock, at cost: 1,028,186 shares at December 31, 2023 and 2022(16,534)(16,534)
Total stockholders’ equity303,722305,297
Total liabilities and stockholders’ equity$434,122$376,147
Trupanion, Inc.Condensed Statements of Cash Flows(Parent Company Only, in thousands)
Year Ended December 31,
202320222021
Operating activities
Net loss$(44,693)$(44,672)$(35,530)
Adjustments to reconcile net loss to cash provided by (used in) operating activities:
Loss attributable to investments in subsidiaries39,18419,33117,501
Dividends from subsidiaries14,8376,9425,567
Depreciation and amortization494289473
Stock-based compensation expense4,57533,39328,226
Other, net4,200533(161)
Changes in operating assets and liabilities6,194(166)(1,219)
Net cash provided by operating activities24,79115,65014,857
Investing activities
Cash paid in business acquisition, net of cash acquired—(15,034)—
Purchases of property and equipment(172)(516)(280)
Advances to and investments in subsidiaries(87,198)(71,671)(71,721)
Other investments1,586(1,598)(1,755)
Net cash used in investing activities(85,784)(88,819)(73,756)
Financing activities
Proceeds from debt financing, net of financing fees59,97269,138—
Repayments of debt financing(1,225)(487)—
Repurchase of common stock—(5,755)—
Proceeds from exercise of stock options2,6552,2903,607
Taxes paid related to net share settlement of equity awards(1,536)(4,359)(4,732)
Net cash (used in) provided by financing activities59,86660,827(1,125)
Net change in cash, cash equivalents, and restricted cash(1,127)(12,342)(60,024)
Cash, cash equivalents, and restricted cash at beginning of period35,08447,426107,450
Cash, cash equivalents, and restricted cash at end of period$33,957$35,084$47,426
  1. Organization and Presentation

The accompanying condensed financial statements present the financial position, results of operations and cash flows for Trupanion, Inc. These condensed unconsolidated financial statements should be read in conjunction with the consolidated financial statements of Trupanion, Inc. and its subsidiaries and the notes thereto (the Consolidated Financial Statements). Investments in subsidiaries are accounted for using the equity method of accounting. Trupanion, Inc. received cash dividends from subsidiaries of $14.9 million, $6.9 million and $5.6 million for the years ended December 31, 2023, 2022 and 2021, respectively. These cash dividends were recorded within Trupanion, Inc.'s other income and were eliminated within the consolidated financial statements of Trupanion, Inc.

The Company has made an immaterial presentation error correction within the Condensed Statements of Cash Flows, reclassifying prior years' dividends from subsidiaries from investing to operating activities. Additional information about Trupanion, Inc.’s accounting policies pertaining to intangible assets, commitments and contingencies, stock-based compensation, stockholders’ equity, and income taxes are set forth in Notes 5, 9, 12, 13, and 17, respectively, to the Consolidated Financial Statements.

Compensation expense related to stock-based transactions, including employee and non-employee stock option awards, restricted stock awards, and restricted stock units, is measured and recognized in the financial statements based on fair value. Effective January 1, 2023, we entered into an intercompany agreement with a non-insurance subsidiary whereby stock-based compensation costs are allocated to this entity. For the year ended December 31, 2023, stock-based compensation expenses of $28.3 million were included within equity (loss) in undistributed earnings of subsidiaries within the Condensed Statements of Operations and Comprehensive Loss and in advances to and investments in subsidiaries in the Condensed Balance Sheets. There was no impact to net income as a result of this intercompany agreement.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.